IBM (IBM) Offering Possible 32.28% Return Over the Next 10 Calendar Days

IBM's most recent trend suggests a bullish bias. One trading opportunity on IBM is a Bull Put Spread using a strike $113.00 short put and a strike $108.00 long put offers a potential 32.28% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $113.00 by expiration. The full premium credit of $1.22 would be kept by the premium seller. The risk of $3.78 would be incurred if the stock dropped below the $108.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for IBM is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for IBM is bullish.

The RSI indicator is at 33.18 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for IBM

Top Insider Buys Highlight for the Week of Nov. 6
Sun, 08 Nov 2020 16:42:05 +0000
The largest Insider Buys this week were for International Business Machines Corp, NXP Semiconductors N.V., Welltower Inc. and Athenex Inc.

Last Week's Notable Insider Buys: Cboe, IBM, Xerox And More
Sat, 07 Nov 2020 19:07:28 +0000
* Insider buying can be an encouraging signal for potential investors when markets face uncertainty. * Activist investor Carl Icahn added to a stake last week. * Financial companies and an options exchange operator saw insiders buying too.Conventional wisdom says that insiders and 10% shareholders really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when markets are near all-time highs.Though buy windows remain closed for many insiders during earnings-reporting season, plenty of others have continued to add shares despite market volatility and economic uncertainty. Here are some of the most noteworthy insider purchases reported in the past week.Carl Icahn, a 10% shareholder of Xerox Holdings Corp. (NYSE: XRX), indirectly added about 1.06 million shares to his stake at prices ranging from $18.26 to $18.93 apiece. That cost him more than $19.45 million and raised the stake to over 28.52 million shares. The total float is less than 210 million.American Assets Trust Inc. (NYSE: AAT) saw Chief Executive Officer Ernest Rady indirectly pick up almost 259,800 shares of this real estate investment trust. At $21.13 to $21.85 per share, the transactions totaled over $6.60 million. Rady also bought more than 45,000 shares in September.A beneficial owner of Esperion Therapeutics Inc. (NASDAQ: ESPR) bought 200,000 shares last week at $25.31 apiece. That totaled more than $5.06 million, and the stake was up to more than 3.94 million shares. Note that this owner also recently bought Molecular Templates Inc. (NASDAQ: MTEM) shares.A Charles River Laboratories Intl. Inc. (NYSE: CRL) director bought shares while others were selling. The 7,200 shares scooped up, at prices ranging from $232.70 to $233.5, totaled almost $1.68 million. The CEO and other executives parted with more than 30,800 shares last week too.An executive at Renasant Corp. (NASDAQ: RNST) picked up 28,000 shares of this Mississippi-based bank holding company. At prices ranging from $28.89 to $29.05 per share, that cost him more than $811,400. The purchase boosted that stake to less than 60,300 shares.Chief Executive Officer Jon Bortz paid between $20.78 and $21.24 each for less than 22,500 Pebblebrook Hotel Trust (NYSE: PEB) shares late last week. That totaled more than $471,800 and brought his stake in this resort-focused real estate investment trust to more than 55.800 shares.Cboe Global Markets Inc. (NYSE: CBOE) saw a director step up to the buy window late in the week. At $85.65 apiece, the more than 5,200 shares of this Chicago-based options exchange operator that he acquired added up to more than $447,900. It also more than doubled his stake.See also: Jeff Bezos Sells Another B Worth Of Amazon SharesAmerican National Group Inc. (NASDAQ: ANAT) saw two directors add shares to their stakes. At prices of $71.47 to $72.52 apiece, the 4,400 shares cost them more than $318,100 altogether. Back in September, two officers ponied up for a combined 335 shares of this insurer.IBM (NYSE: IBM) had a director acquire over 2,600 shares of the old-school tech giant early last week. At $112.92 per share, that totaled about $299,800. Note that five other directors purchased more than 18,700 shares altogether in the previous week for less than $111 apiece.And an Enterprise Financial Services Corp. (NYSE: EFSC) director added 10,000 more shares via trust of this Missouri-based company last week. At $29.32 to $30.08 per share, that cost him about $298,600 and lifted his stake to over 78,000 shares. Note that this director also bought 100,000 shares in August.There also was some smaller amounts of insider buying at Bed Bath & Beyond Inc. (NASDAQ: BBBY), Del Taco Restaurants Inc. (NASDAQ: TACO), First Financial Bankshares Inc. (NASDAQ: FFIN) and Sprouts Farmers Market Inc. (NASDAQ: SFM) posted last week.At the time of this writing, the author had no position in the mentioned equities.Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.See more from Benzinga * Click here for options trades from Benzinga * Benzinga's Bulls And Bears Of The Week: Apple, Toyota, Verizon And More * Barron's Picks And Pans: AT&T, GE, Zynga And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

AMD Stock Is Higher on Another Upgrade to Buy
Fri, 06 Nov 2020 20:38:00 +0000
Wells Fargo analyst Aaron Rakers increased the bank’s target price to $100 from $83, citing the company’s potential in high-performance computing.

Former Vanguard Group CEO Bill McNabb Bought Up IBM Stock
Fri, 06 Nov 2020 19:39:00 +0000
Bill McNabb, retired chairman and CEO of investment giant Vanguard Group, bought about $1 million of shares of software giant IBM, which he serves as a director. Other IBM directors also purchased shares.

3 Dividend Technology Stocks With Yields Of 2.5% And Up
Thu, 05 Nov 2020 21:18:14 +0000
Many technology companies do not pay dividends, as they tend to invest profits back into the growth of the company or use it for acquisitions.Here's a look at three technology companies with dividend yields greater than 2.5% that could be good picks for investors.IBM: The dividend yield of International Business Machines Corporation (NYSE: IBM) is now above 5.7%. Shares of the tech giant have fallen 15% in 2020.IBM reported a 3% year-over-year decline in third-quarter revenue to $17.6 billion. The company said its Cloud & Cognitive Software segment had 7% year-over-year growth.Overall cloud revenue across all IBM business segments was up 19% year-over-year to $6 billion in the third quarter. Over the last 12 months, cloud-related revenue has increased 25% year-over-year to $24.4 billion for the company.”The strong performance of our cloud business, led by Red Hat, underscores the growing client adoption of our open hybrid cloud platform,” said IBM CEO Arvind Krishna.The company could be a great play on the increased shift to the cloud during the pandemic. The company said it is well-positioned to “seize the $1-trillion hybrid cloud opportunity.”IBM pays out a quarterly dividend of $1.63. The company increases this amount for its February payout and could announce a raise during its next quarterly earnings report.Related Link: How The 2020 Presidential Election Could Impact Tech StocksCisco Systems: Shares of Cisco Systems Inc (NASDAQ: CSCO) are down over 20% in 2020. The company's dividend yield that is close to 4%.Third-quarter revenue declined 9% year-over-year for Cisco. The company's largest division of infrastructure platforms saw quarterly revenue fall 15% year-over-year in the quarter. Security segment revenue was the bright spot, with 6% year-over-year growth.Software subscriptions represented 74% of software segment revenue in the third quarter.”We executed well in Q3 in a very challenging environment, delivering strong margins and non-GAAP EPS growth,” said Cisco CFO Kelly Kramer.The dividend payment for Cisco is typically raised every December. The last dividend increase was a penny, going from 35 to 36 cents. The prior increases were from 26 cents to 29 cents; 29 cents to 33 cents; and 33 cents to 35 cents.Corning: Shares of Corning Incorporated (NYSE: GLW) are up 15% year-to-date, which has brought the dividend yield of shares below 3%.Corning yields over 2.6% and is likely to raise its dividend with the next quarterly earnings report.Third-quarter revenue increased 1% year-over-year to $3 billion. The company said all five of its market segments had a strong third quarter.Corning's mobile consumer electronics segment could get a strong boost from its relationship with Apple Inc (NASDAQ: AAPL).Corning was unveiled as the company behind “ceramic shield” on the new iPhone 12. The ceramic shield is the world's first transparent, color-free glass ceramic. The technology provides 4x the drop protection of previous iPhone models.The company is also providing glass vials for COVID-19 vaccine makers as part of Operation Warp Speed. This could be a great growth opportunity for the company after a vaccine is approved.Corning's optical communications division is working with Verizon Communications (NYSE: VZ) on its 5G rollout.See more from Benzinga * Click here for options trades from Benzinga * Democratic DEMZ ETF Launches On Election Day: What Investors Should Know * IBM, Pfizer Collaborate On Early Alzheimer's Detection With Artificial Intelligence(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.